Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7380
    -0.0007 (-0.09%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    94,684.41
    -773.82 (-0.81%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,379.46
    -20.06 (-0.12%)
     
  • VOLATILITY

    13.01
    0.00 (0.00%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • CAD/EUR

    0.6842
    -0.0001 (-0.01%)
     

Biosenta Announces Record Revenues

CALGARY, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360. The Purchase Order is for an initial order of 145 drums (30,160 litres) of TRUE disinfectant and continued monthly orders.

This marks a milestone for Biosenta of achieving record revenues as it continues to implement its strategic plan to position the company to be a leader in the growing disinfectant market in North America. The agreement with SANITIZATION 360 is a perfect fit for Biosenta’s growth plans and aligns itself with a company that sells leading edge disinfectants products.

About SANITIZATION 360

SANITIZATION 360 is a Canadian sanitization and disinfectant company with leading-edge products to combat viruses and bacteria.

ADVERTISEMENT

About Biosenta

Biosenta develops and manufactures a range of wet and dry anti-microbial chemical compounds for household and industrial applications using active material, and advanced encapsulated nanotechnology.

Disclaimer

In no way, the CSE has passed upon the contents of this news release and further has neither approved nor disapproved of the contents of this news release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the CSE) accepts responsibility for this release's adequacy or accuracy.

Biosenta Digital channel:

https://www.Biosenta.com

Contact Information:

Am Gill
President and CEO
T: 416-410-2019

For further information on the project,
please contact:

Sales
Biosenta Inc.
34 Wrangler Place, Suite 10
Rocky View County, Alberta T1X 0L7
T: 416-410-2019
E: sales@biosenta.com

For Investor Relations,
please contact:

Investor Relations
Biosenta Inc.
18 Wynford Drive, Suite 704
Toronto, Ontario M3C 3S2
T: 416-410-2019
E: info@biosenta.com